These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


416 related items for PubMed ID: 18815449

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Wang M, Chan IH, Lui SF, Zhang Y, Sanderson JE.
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [Abstract] [Full Text] [Related]

  • 8. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
    Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Udompunturak S.
    Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
    [Abstract] [Full Text] [Related]

  • 9. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP.
    J Am Coll Cardiol; 2005 May 17; 45(10):1667-71. PubMed ID: 15893185
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
    Racek J, Králová H, Trefil L, Rajdl D, Eiselt J.
    Nephron Clin Pract; 2006 May 17; 103(4):c162-72. PubMed ID: 16645318
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
    Dini FL, Fontanive P, Conti U, Andreini D, Cabani E, De Tommasi SM.
    Am Heart J; 2008 Jun 15; 155(6):1121-7. PubMed ID: 18513528
    [Abstract] [Full Text] [Related]

  • 19. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE.
    J Am Soc Nephrol; 2007 Jan 15; 18(1):321-30. PubMed ID: 17167121
    [Abstract] [Full Text] [Related]

  • 20. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
    Iltumur K, Yavavli A, Apak I, Ariturk Z, Toprak N.
    Am Heart J; 2006 May 15; 151(5):1115-22. PubMed ID: 16644347
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.